Please wait
Calculation of Filing Fee Tables
Form S-3
(Form Type)
Akebia Therapeutics, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Security Type | Security Class Title | Fee Calculation or Carry Forward Rule | Amount Registered | Proposed Maximum Offering Price Per Unit | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee | Carry Forward Form Type | Carry Forward File Number | Carry Forward Initial Effective Date | Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward |
| Newly Registered Securities |
| Fees to Be Paid | Debt | Debt Securities | (1) | (1) | (1) | (1) | (1) | (1) | - | - | - | - |
| Fees to Be Paid | Equity | Common Stock, $0.00001 par value per share | (1) | (1) | (1) | (1) | (1) | (1) | - | - | - | - |
| Fees to Be Paid | Equity | Preferred Stock, $0.00001 par value per share | (1) | (1) | (1) | (1) | (1) | (1) | - | - | - | - |
| Fees to Be Paid | Other | Warrants(2) | (1) | (1) | (1) | (1) | (1) | (1) | - | - | - | - |
| Fees to Be Paid | Other | Units(3) | (1) | (1) | (1) | (1) | (1) | (1) | - | - | - | - |
| Fees to Be Paid | Unallocated (Universal) Shelf | Unallocated (Universal) Shelf | 457(o) | (1) | (1) | $250,000,000(1)(4) | 0.00014760 | $36,900.00 | - | - | - | - |
| Fees Previously Paid | - | - | - | - | - | - | - | - | - | - | - | - |
| Carry Forward Securities |
| Carry Forward Securities | - | - | - | - | - | - | | - | - | - | - | - |
| Total Offering Amounts | | $250,000,000(1)(4) | | $36,900.00 | | | | |
| Total Fees Previously Paid | | | | - | | | | |
| Total Fee Offsets(4) | | | | $25,399.80 | | | | |
| Net Fee Due | | | | $11,500.20 | | | | |
Table 2: Fee Offset Claims and Sources
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Registrant or Filer Name | Form or Filing Type | File Number | Initial Filing Date | Filing Date | Fee Offset Claimed | Security Type Associated with Fee Offset Claimed | Security Title Associated with Fee Offset Claimed | Unsold Securities Associated with Fee Offset Claimed | Unsold Aggregate Offering Amount Associated with Fee Offset Claimed | Fee Paid with Fee Offset Source
|
| Rule 457(p) |
| Fee Offset Claims | Akebia Therapeutics, Inc. | S-3 | 333-253539 | February 25, 2021 | - | $25,399.80(4) | Unallocated
(Universal)
Shelf | Unallocated
(Universal)
Shelf | Unallocated
(Universal)
Shelf | $274,000,000(4) |
— |
| Fee Offset Sources | Akebia Therapeutics, Inc. | S-3 | 333-253539 | - | February 25, 2021 | - | - | - | - | - |
$25,399.80(4) |
(1)Pursuant to Instruction 2.A(iii)(b) of Item 16(b) of Form S-3, this information is not required to be included. An indeterminate amount of the securities of each identified class is being registered as may from time to time be offered under this registration statement at indeterminate prices, along with an indeterminate number of securities that may be issued upon exercise, settlement, exchange or conversion of securities offered or sold under this registration statement, as shall have an aggregate initial offering price up to $250,000,000. Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement also covers any additional securities that may be offered or issued in connection with any stock split, stock dividend or pursuant to anti-dilution provisions of any of the securities. Separate consideration may or may not be received for securities that are issuable upon conversion, exercise or exchange of other securities. In addition, the total amount to be registered and the proposed maximum aggregate offering price are estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(o) under the Securities Act.
(2)The warrants covered by this registration statement may be warrants to purchase common stock, preferred stock or debt securities.
(3)Units may be issued under a unit agreement and will represent an interest in one or more securities registered under this registration statement including shares of common stock or preferred stock, debt securities or warrants, in any combination, which may or may not be separable from one another.
(4)Pursuant to Rule 457(p) under the Securities Act, the registration fee applicable to the $250,000,000 of securities of the registrant being registered hereby in the amount of $36,900.00 is offset by $25,399.80, which represents the registration fee previously paid with respect to $274,000,000 of unsold securities under the registrant’s Registration Statement on Form S-3 (File No. 333-253539) that became effective upon filing with the Securities and Exchange Commission (the “SEC”) on February 25, 2021, as amended by Post-Effective Amendment No. 1 thereto that became effective upon filing with the SEC on March 1, 2022 and by Post-Effective Amendment No. 2 thereto, which was declared effective by the SEC on April 28, 2022. All offerings of the unsold securities associated with the claimed fee offset pursuant to Rule 457(p) have been completed or terminated.